ArticleJournal for immunotherapy of cancer2017

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy.

Ghayathri Jeyakumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.